Background: Carbon monoxide-releasing molecules (CORMs) are a novel group of substances that are capable of modulating physiological functions via the liberation of CO. Aims: This study was undertaken to investigate the effects of CORM-3, a water-soluble CO-releasing agent, on two rabbit models of ocular hypertension. Methods: Ocular hypertension was induced by injecting a-chymotrypsin in the rabbit eye. The dose-response effect of CORM-3 on IOP was assessed by topical administration of the drug (0.001, 0.01, 0.1 and 1%). Ocular hypertension was also obtained by weekly subconjunctival injection of betamethasone, and animals were treated topically with CORM-3. A group of animals in both models was treated with the inactive form of the drug (iCORM-3). Results: CORM-3 induced a dose-dependent reduction in IOP in rabbits treated with a-chymotrypsin. A similar reduction in IOP was observed in rabbits with beta-methasone-induced ocular hypertension treated with the drug. Treatment with the iCORM-3 had no effect on IOP in both models. Conclusions: Treatment with CORM-3 is associated with a reduction in IOP in two different rabbit models of ocular hypertension. These results support previous findings on the effect of haem oxygenase-derived CO on IOP and suggest a direct involvement of CO system in the regulation of ocular pressure probably through the modulation of aqueous humour dynamics.
|Titolo:||A water-soluble carbon monoxide-releasing molecule (CORM-3) lowers intraocular pressure in rabbits|
|Autori interni:||BUCOLO, CLAUDIO|
LEGGIO, GIAN MARCO
|Data di pubblicazione:||2009|
|Rivista:||BRITISH JOURNAL OF OPHTHALMOLOGY|
|Appare nelle tipologie:||1.1 Articolo in rivista|